{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T07:46:33Z","timestamp":1776498393328,"version":"3.51.2"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bbrc.2024.150455","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T01:35:45Z","timestamp":1722044145000},"page":"150455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Interleukin-8 in HepG2 cells: Enhancing antiviral proteins in uninfected cells but promoting HBV replication in infected cells"],"prefix":"10.1016","volume":"734","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8684-3309","authenticated-orcid":false,"given":"Kai","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bbrc.2024.150455_bib1","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.3390\/ijms22115497","article-title":"Immunopathology of chronic hepatitis B infection: role of innate and adaptive immune response in disease progression","volume":"22","author":"Khanam","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.bbrc.2024.150455_bib2","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/jama.2018.3795","article-title":"Chronic hepatitis B infection: a review","volume":"319","author":"Tang","year":"2018","journal-title":"JAMA"},{"issue":"1\u20132","key":"10.1016\/j.bbrc.2024.150455_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.virol.2013.06.028","article-title":"Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha","volume":"444","author":"Pollicino","year":"2013","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.bbrc.2024.150455_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41423-023-00974-6","article-title":"The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention","volume":"20","author":"Cambier","year":"2023","journal-title":"Cell. Mol. Immunol."},{"issue":"5","key":"10.1016\/j.bbrc.2024.150455_bib5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/QAI.0b013e3181e5e12c","article-title":"IL-8 decreases HIV-1 transcription in peripheral blood lymphocytes and ectocervical tissue explants","volume":"54","author":"Rollenhagen","year":"2010","journal-title":"Journal of acquired immune deficiency syndromes, J. Acquir. Immune Defic. Syndr."},{"issue":"4","key":"10.1016\/j.bbrc.2024.150455_bib6","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2567.2005.02185.x","article-title":"Induction of interleukin-8 production via nuclear factor-kappaB activation in human intestinal epithelial cells infected with Vibrio vulnificus","volume":"115","author":"Lee","year":"2005","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.bbrc.2024.150455_bib7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/hep.21752","article-title":"Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes","volume":"46","author":"Joshi-Barve","year":"2007","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.bbrc.2024.150455_bib8","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1158\/0008-5472.CAN-20-3453","article-title":"Hepatitis B-induced IL8 promotes hepatocellular carcinoma venous metastasis and intrahepatic treg accumulation","volume":"81","author":"Zhang","year":"2021","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bbrc.2024.150455_bib9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jhep.2004.01.007","article-title":"Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis C","volume":"40","author":"Mihm","year":"2004","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150455_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/08820139.2010.508192","article-title":"Evaluation of interleukin-8 in hepatitis C virus infection: relation to combined peg-interferon ribavirin response and genotype 4","volume":"40","author":"El Sayed","year":"2011","journal-title":"Immunol. Invest."},{"issue":"2","key":"10.1016\/j.bbrc.2024.150455_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jhep.2009.11.003","article-title":"Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection","volume":"52","author":"Crotta","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2024.150455_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1052917","article-title":"CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.bbrc.2024.150455_bib13","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.bbrc.2017.03.150","article-title":"Interferon induces interleukin 8 and bone marrow stromal cell antigen 2 expression, inhibiting the production of hepatitis B virus surface antigen from human hepatocytes","volume":"486","author":"Haga","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2024.150455_bib14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virol.2018.08.020","article-title":"Endoplasmic reticulum-mediated induction of interleukin-8 occurs by hepatitis B virus infection and contributes to suppression of interferon responsiveness in human hepatocytes","volume":"525","author":"Tsuge","year":"2018","journal-title":"Virology"},{"issue":"16","key":"10.1016\/j.bbrc.2024.150455_bib15","doi-asserted-by":"crossref","first-page":"7885","DOI":"10.1128\/JVI.00519-06","article-title":"Relationships between hepatitis C virus replication and CXCL-8 production in vitro","volume":"80","author":"Koo","year":"2006","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150455_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s13046-019-1455-x","article-title":"Interleukin-8 promotes integrin \u03b23 upregulation and cell invasion through PI3K\/Akt pathway in hepatocellular carcinoma","volume":"38","author":"Sun","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bbrc.2024.150455_bib17","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1053\/j.gastro.2015.05.058","article-title":"Interleukin-8 induces expression of FOXC1 to promote transactivation of CXCR1 and CCL2 in hepatocellular carcinoma cell lines and formation of metastases in mice","volume":"149","author":"Huang","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bbrc.2024.150455_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11033-010-0087-1","article-title":"IL-29 and IFN-\u03b1 regulate the expression of MxA, 2\u2019,5\u2019-OAS and PKR genes in association with the activation of Raf-MEK-ERK and PI3K-AKT signal pathways in HepG2.2.15 cells","volume":"38","author":"Chai","year":"2011","journal-title":"Mol. Biol. Rep."},{"issue":"48","key":"10.1016\/j.bbrc.2024.150455_bib19","doi-asserted-by":"crossref","first-page":"19011","DOI":"10.1073\/pnas.0706696104","article-title":"Protein phosphatase 2A regulates life and death decisions via Akt in a context-dependent manner","volume":"104","author":"Andrabi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2024.150455_bib20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/1479-5876-12-206","article-title":"In vitro blood cell responsiveness to IFN-\u03b1 predicts clinical response independently of IL28B in hepatitis C virus genotype 1 infected patients","volume":"12","author":"Bourke","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbrc.2024.150455_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.805625","article-title":"Cytokines and chemokines in HBV infection","volume":"8","author":"Zhong","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"4","key":"10.1016\/j.bbrc.2024.150455_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41577-019-0131-x","article-title":"Cytokine-mediated communication: a quantitative appraisal of immune complexity","volume":"19","author":"Altan-Bonnet","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.bbrc.2024.150455_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105163","article-title":"Epigenetic inactivation of inositol polyphosphate 4-phosphatase B (INPP4B), a regulator of PI3K\/AKT signaling pathway in EBV-associated nasopharyngeal carcinoma","volume":"9","author":"Yuen","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbrc.2024.150455_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/jlb.64.1.62","article-title":"Potential involvement of IL-8 in the pathogenesis of human cytomegalovirus infection","volume":"64","author":"Murayama","year":"1998","journal-title":"J. Leukoc. Biol."},{"issue":"18","key":"10.1016\/j.bbrc.2024.150455_bib25","doi-asserted-by":"crossref","first-page":"10072","DOI":"10.1128\/JVI.00541-07","article-title":"Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-akt signal transduction pathway","volume":"81","author":"Guo","year":"2007","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.bbrc.2024.150455_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2893.2010.01315.x","article-title":"Control of hepatitis B virus at the level of transcription","volume":"17","author":"Quasdorff","year":"2010","journal-title":"J. Viral Hepat."},{"issue":"5","key":"10.1016\/j.bbrc.2024.150455_bib27","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1074\/jbc.274.5.2858","article-title":"Interaction of hepatitis B viral X protein and CCAAT\/enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II\/pregenomic promoter","volume":"274","author":"Choi","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bbrc.2024.150455_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002159","article-title":"Effects of interferon-\u03b1\/\u03b2 on HBV replication determined by viral load","volume":"7","author":"Tian","year":"2011","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.bbrc.2024.150455_bib29","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1038\/s41598-017-01773-6","article-title":"Hepatitis B Virus e Antigen Activates the Suppressor of Cytokine Signaling 2 to Repress Interferon Action","volume":"7","author":"Yu","year":"2017","journal-title":"Sci. Rep."},{"issue":"Pt 8","key":"10.1016\/j.bbrc.2024.150455_bib30","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1099\/vir.0.18966-0","article-title":"Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore\/core proteins","volume":"84","author":"Fern\u00e1ndez","year":"2003","journal-title":"J. Gen. Virol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24009914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24009914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T19:31:20Z","timestamp":1732649480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24009914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":30,"alternative-id":["S0006291X24009914"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150455","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-8 in HepG2 cells: Enhancing antiviral proteins in uninfected cells but promoting HBV replication in infected cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150455"}}